Loading stock data…
ICU Medical, Inc. (ICUI)
$160.89-6.69 (-3.99%)
Market ClosedLast close Sep 8
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ICU Medical, Inc. in the Healthcare sector is trading at $160.89 with a market capitalization of $4.5B. Wall Street consensus targets $193.38 (8 analysts), implying a +20.2% move over the next 12 months. The stock is currently 17% below its 52-week high of $192.85, remaining 10.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: RSI 15 is oversold, raising the odds of a near-term bounce. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 15) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $530.23M↓ | $540.70M↑ | $536.99M↓ | $548.87M↓ | $604.70M |
| Gross Profit | $206.23M↑ | $202.99M↑ | $200.88M↓ | $208.06M↓ | $210.11M |
| Operating Income | $30.38M↑ | $26.09M↓ | $26.86M↑ | $26.80M↓ | $29.59M |
| Net Income | $30.13M↑ | -$15.73M↓ | -$3.40M↓ | $35.34M↑ | -$15.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroCla...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.48B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
151.98
Beta
Defensive asset. Lower volatility than the S&P 500.
0.75
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.41%
Volume
Today's trading volume
311,076
Recent News
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
Let’s dig into the relative performance of ICU Medical (NASDAQ:ICUI) and its peers as we unravel the now-completed Q2 medical devices & supplies - cardiology, neurology, vascular earnings season.
1 Small-Cap Stock with Promising Prospects and 2 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?
ICU Medical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.3%. The stock now trades at $182.79, marking a 23.3% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call
ICU Medical’s second quarter results were well received by the market, with management highlighting robust performance in the Infusion Systems and Consumables segments as key drivers. CEO Vivek Jain emphasized that North America led growth, and noted that “record quarters” in both pumps and consumables reflected broad-based demand and incremental wins. Operational efficiencies stemming from IT system integration and facility consolidation also contributed to improved operating margins. Managemen
2 Russell 2000 Stocks to Target This Week and 1 That Underwhelm
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.